Don't You Need Somebody To Love Tiktok Remix, Neo Geo Games List, Lost Knife Hideout Sabercat, Kashi Cinnamon French Toast Nutrition, Kevin Plank Height, " />

gsk relocation package

by

(Unvested awards will lapse. stream 350.921 251.347 5.0999 5.1 re -.4199 -1.6772 TD [(C)-22.7(E)4.4(O a)-15.1(n)-11.2(d C)-23.2(F)-21.1(O r)-13.8(e)-19.4(s)-14.9(p)-15.2(e)-15.6(c)-16.6(t)-8(i)-16.1(ve)-13.5(l)-13.7(y)23(. -.0002 Tw 10.9953 0 0 10.9953 45.3349 286.0412 Tm .0093 Tc -.0208 Tc 243.676 0 l 19635 [(b)-15.7(e)-9.2(t)-30.3(w)-3.1(e)-15.7(e)-14.2(n i)-12.3(n)-8.6(i)-14.4(t)-8.1(i)-15(a)-4.8(t)-8.1(i)-14.1(o)-13.2(n).4( o)-9.6(f).4( a)-15.2(n).4( a)-11(d)-15.7(ve)-13.7(r)-22.8(s)-15.8(e eve)-14.2(n)-7.8(t a)-15.2(n)-11.3(d i)-14.4(t)-10.5(s e)-14.1(m)-13.1(e)-13.7(r)-13.8(g)-13.2(e)-14.2(n)-11.3(c)-19.5(e a)-22.3(s).4( a)-19.6( )]TJ 6.997 0 0 6.997 301.7606 382.9534 Tm BT ( )Tj T* [(Non-Executive Dir)20(ectors)]TJ /Cs8 cs 1 scn -5.265 -9.6779 TD -2.7979 -1.711 TD -34.185 -1.2 TD << -.001 Tw -.0086 Tc [(remunera)9.2(t)5.9(ion. S 1 0 0 1 164.34 0 cm 0 0 m -.0089 Tc -.0196 Tc 20171 /F1 1 Tf ).3( O)-26.6(t)-8.3(h)-12.8(e)-13.8(r)-19.7( )]TJ [(31)18.5(%)]TJ 498.684 0 l [(to a review of the Chairman�)62(s performance and independently sourced market dat)-21(a. 1 scn 0 -1.1759 TD 1.134 -1.2 TD 1 i 19.3383 0 TD The pros are the opportunity to learn new aspects of other roles. T* 0 -1.1759 TD 0 -1.2001 TD [(r)-14.1(e)-20(s)-15.8(o)-13.1(l)-15.3(v)-2.2(e)-16.2(d)-17.6(, w)-17.7(h)-13.2(e)-14.1(r)-14.1(e)0( i)-14.9(t)-.1( i)-14.1(s)-.1( l)-13.6(e)-15.3(g)-15.5(a)-15.7(l)-10(l)-14.1(y p)-15.8(e)-14.1(r)-18.6(m)-11.1(i)-14.1(s)-22.8(s)-14.7(i)-12.2(b)-14.1(l)-13.6(e to d)-9.9(i)-14.1(s)-16.3(c)-15(l)-13.2(o)-15.7(s)-16.3(e)-.1( a)-15.7(n)-11.8(d w)-17.7(h)-13.2(e)-14.1(r)-14.1(e)-.1( i)-14.9(t)-.1( c)-23.3(a)-15.7(n)-20.1( )]TJ )]TJ [(i)-14.7(n)-10.2(te)-16(l)-11.9(l)-15.5(e)-18.1(c)-19.1(t)-7.4(u)-16.5(a)-17.7(l).3( p)-15.6(r)-14.9(o)-15.2(p)-17.7(e)-16.1(r)-42.9(t)-31.2(y).3( a)-17.6(n)-13.7(d s)-18.2(t)-20(a)-9.7(f)-41(f. I)-24(n).3( l)-10.9(i)-16(g)-13.5(h)-11.6(t o)-12.1(f).3( t)-10.6(h)-12.4(i)-16.4(s)-26.1(, t)-10.6(h)-15.1(e C)-31.1(o)-15.6(m)-15.1(m)-13(i)-16.8(t)-30.3(te)-18.1(e)-19.7( )19.8( )]TJ /F3 1 Tf (Remuneration)Tj /Length 33 0 R [(p)-17.5(o)-15.4(l)-11.3(i)-17.2(c)-12.9(y)0( o)-15.9(n)0( r)-16.5(e)-11.9(t)-10.9(i)-14.5(r)-16.5(e)-16.9(m)-15.8(e)-16.9(n)-10.5(t)0( a)-12.4(g)-15.9(e)-17.7(,)0( w)-19.8(h)-12.7(i)-17.2(c)-16.5(h s)-16.8(i)-15(n)-14(c)-22.2(e 2)-5.2(0)-26.1(0)-20.2(9)0( h)-15.5(a)-24.9(s b)-18.4(e)-18.4(e)-16.9(n 6)-18.8(5)-18.4(. 238.008 -17.001 l S -.014 Tw 0 -1.176 TD 30.014 35.776 TD [(14)-74.1(4)]TJ [(Executive Directors may be accompanied by their spouse or partner to these meetings or)-20( )]TJ 243.676 -17.001 243.676 -11.335 v /Cs6 cs .38431 .73333 .27451 scn /GS1 gs [(Governance and r)20(emuneration)]TJ 0 -1.6771 TD [(P)20(erformance measur)20(es)]TJ -.025 Tc BT -.0002 Tw U)-15.6(p)0( to 3)-16.6(0)-26.4(% o)-10(f)0( aw)-5.3(a)-15.2(r)-15.2(d)-14.4(s w)-16.1(i)-11.3(l)-9.9(l)0( ve)-19.9(s)-16.1(t)0( a)-5.2(t)-10( )]TJ /F3 1 Tf -.0002 Tw All content is posted anonymously by employees working at GlaxoSmithKline. 239.677 -8.501 l 0 -1.1759 TD q 1 0 0 1 56.669 562.174 cm 0 0 m /Cs6 cs .95294 .43529 .12941 scn [(…)-554(F)20(ormally include the shareholding guidelines)-20( )19.9( )]TJ 1.999 w [(m)-13.2(a)-41.1(x)-14.8(i)-12.3(m)-10.7(u)-11.1(m l)-13.1(e)-2.1(ve)-13.6(l a)-15.2(n)-11.3(d t)-8.2(h)-12.8(a)-4.8(t).4( t)-8.2(h)-12.7(e aw)-5(a)-14.8(r)-14.8(d)-14(s u)-11.1(n)-11.3(d)-13.2(e)-13.7(r t)-8.2(h)-12.7(e P)-24(S)-22.9(P wo)-11.3(u)-9.4(l)-13.1(d ve)-19.5(s)-15.6(t)-19.6( )19.7( )]TJ /ProcSet [/PDF /Text] ET -.0065 Tc 0 -1.176 TD ET ( )Tj .0009 -3.1871 TD 9.9957 0 0 9.9957 178.2784 327.1263 Tm [(Redundancy)41(, r)20(etir)20(ement, death, ill-health, injury)41(, disability or any other r)20(eason: )]TJ 243.676 0 l ( )Tj ET 0 -1.1759 TD -.0194 Tc 0 -1.176 TD .0003 Tw S -.0004 Tw .0001 Tw 3. 0 -1.176 TD 1.6914 0 TD endstream /F1 1 Tf [(D)20(A)0(B)-42(P)0( deferr)20(ed)-20( )20( )]TJ -.0197 Tc /Cs6 cs 0 .71373 .78824 scn BT 208.981 0 l 0 Tc [(C)-31.3(o)-15.8(n)-10.4(t)-11.3(r)-20.7(a)-13.2(c)-19.3(t)-13.2(s f)-8.6(o)-15.4(r e)-8(x)-17.4(i)-16.6(s)-18.4(t)-10.8(i)-14.8(n)-12.9(g).1( E)-42.9(x)-7.2(e)-18.2(c)-15.1(u)-15.5(t)-10.7(i)-18.8(v)-4.3(e D)-21.9(i)-14.4(r)-16.4(e)-18.3(c)-19.3(t)-.6(o)-15.4(r)-25.4(s w)-18.4(i)-13.5(l)-12.1(l).1( e)-8(x)-19.3(p)-14.8(i)-14.4(r)-16.4(e).1( o)-15.8(n).1( t)-10.8(h)-15.3(e d)-17.6(a)-7.5(te)-22.1(s s)-17.1(h)-14.8(o)-5.3(w)-20.6(n)-19.9( )]TJ 20855 229.011 0 l .5161 -3.248 TD Q -.02 Tc GSK assumes no responsibility for the site. ET [(T)82(ravel and subsistence costs for Non-Executive Directors are incurred in the normal course)-20( )]TJ /Cs8 CS .65 SCN s)-14(i)-13.4(g)-11.9(n)-8.4(i)-21.6(“)-18.6(c)-22.6(a)-15(n)-7.6(t).6( m)-10.4(i)-13.8(s)-15.6(c)-18.9(o)-13(n)-11.1(d)-10.6(u)-12.1(c)-16.5(t).6( by w)-4.8(a)2.8(y)-19.4( )]TJ [(E)-7.1(t)-8.6(h)-10.4(i)-15(c)-25.1(s)0( a)-15.6(n)-11.7(d C)-29.3(o)-13.6(m)-12.9(p)-13.5(l)-8.9(i)-15(a)-15.6(n)-11.7(c)-19.9(e)-15(, a)-15.6(n)-11.7(d t)-8.6(h)-13.1(e S)-16.9(e)-15(n)-9(i)-14.5(o)-13.2(r)0( V)-19.9(i)-15(c)-19.9(e)0( P)-21.6(r)-14.3(e)-19.9(s)-15(i)-15(d)-13.6(e)-15(n)-8.2(t & G)-22.2(e)-15(n)-11.7(e)-14.1(r)-18.5(a)-15.6(l)-20( )]TJ -.0144 Tw .0001 -1.176 TD f )-19.4( )]TJ 0 -1.176 TD 6.7471 0 0 7.4968 399.5138 802.8964 Tm 8.4964 0 0 8.4964 60.9188 702.6431 Tm -.0198 Tc Find information about retirement plans, insurance benefits, paid time off, reviews, and more. 8.7921 5.7099 TD T* 6.997 0 0 6.997 476.0819 635.0049 Tm 0 -22.667 5.667 -22.667 v .0003 Tc 10.205 0 TD [(e)-14(n)-7.6(t)-7.9(i)-14.2(t)-8.7(l)-12.9(e)-14(m)-12.9(e)-14(n)-7.6(t)-10.3(s).6( a)-14.9(n)-11.1(d a)-15(n)1.4(y o)-11.1(u)-12.6(t)-10.4(s)-15.4(t)-17.5(a)-15(n)-11.1(d)-9.2(i)-12.1(n)-10.1(g aw)-4.8(a)-14.6(r)-14.6(d)-13.8(s)-25.2(. [(o)-10.2(f)-.2( o)-11.9(u)-13.5(t)-11.1(s)-16.3(t)-18.3(a)-15.8(n)-11.9(d)-10(i)-12.9(n)-10.9(g i)-12.9(n)-11.9(c)-20.1(e)-14.8(n)-8.4(t)-8.7(i)-16.8(v)-2.3(e aw)-5.6(a)-15.4(r)-15.4(d)-14.6(s \()15.8(m)-13.9(a)-15.8(l)-10.6(u)-13.8(s)29.5(\), to e)-14.8(n)-10.7(s)-14.1(u)-11.3(r)-14.5(e)-.2( t)-8.8(h)-13.4(a)-5.4(t)-.2( a)-15.8(n).6(y)-20.2( )]TJ [(c)-21.7(o)-15.9(n)-10.5(t)-11.4(r)-20.8(a)-13.3(c)-19.4(t)-13.3(s f)-8.7(o)-15.5(r n)-14(e)-6.3(w a)-17.5(p)-15.9(p)-17.5(o)-14.4(i)-15(n)-10.5(t)-11.9(m)-15.8(e)-16.9(n)-10.5(t)-13.2(s)0( w)-18.6(i)-13.5(l)-12.2(l)0( e)-8.1(x)-19.4(p)-14.9(i)-14.5(r)-16.5(e)0( i)-15(n)0( l)-11.3(i)-15(n)-14(e)0( w)-18.5(i)-17.1(t)-10.9(h)0( t)-10.9(h)-15.4(e a)-17.5(p)-15.9(p)-15.8(l)-11.3(i)-17.2(c)-25.4(a)-17.5(b)-16.3(l)-15.8(e)-20( )]TJ 17 0 obj /F3 1 Tf -.0002 Tw [(t)-7.8(h)-12.3(e r)-13.5(e)-13.2(l)-12.7(e)-1.7(va)-14.8(n)-7.4(t).8( m)-10.3(u)-9(l)-12.6(t)-7.7(i)-11.4(p)-12.7(l)-12.7(e)-19.1(s f)-5.4(o)-12.4(r 20)24.5(1)76.7(7)69(. /F3 1 Tf )Tj [(13)-71.8(8)]TJ 0 -1.1759 TD Q -.02 Tc 0 1.56 TD W n Q stream 498.684 -22.667 498.684 -17.001 v 6.7471 0 0 7.4968 399.5138 785.8958 Tm -.0195 Tc T* /Cs6 cs .38431 .73333 .27451 scn [(t)-13.3(h)-17.8(e c)-27.7(a)-27.2(s)-20.7(e)0( o)-14.8(f)0( a)-20.2(n)0( E)-45.3(x)-9.6(e)-20.7(c)-17.5(u)-18(t)-13.2(i)-21.2(v)-6.8(e D)-24.4(i)-16.8(r)-18.9(e)-20.7(c)-21.7(t)-3.2(o)-17.8(r)25.1(,)-20( )]TJ .0037 Tc -.025 Tc Q 30.004 18.648 TD /F1 1 Tf -.0066 Tc S Learn about GlaxoSmithKline , including insurance benefits, retirement benefits, and vacation policy. -30.004 -5.9549 TD [(…)-554(Provide additional ”exibility for the Committee)-20( )]TJ [(Per)-26.8(f)3.3(orm)-6.1(a).1(n)-6.1(c)-3.7(e S)-8(h)-4.6(are Pl)-6.2(an \()6.2(P)-10(S)-9.5(P)24.9(\) )]TJ 0 -1.677 TD /GS1 gs ET -.0198 Tc 6.997 0 0 6.997 39.668 808.252 Tm -43.843 -3.1371 TD /Cs6 cs 0 .71373 .78824 scn -11.8681 -2.494 TD -.0197 Tc /F1 1 Tf ET 0 -1.176 TD [(T)-19.9(h)-13.2(e)-14.2(r)-14.4(e i)-14.5(s)-.1( n)-11.3(o)-.1( f)-6.3(o)-13.3(r)-18.6(m)-13.7(a)-15.7(l)-.1( m)-13.7(a)-41.6(x)-15.3(i)-12.8(m)-11.2(u)-11.6(m l)-9(i)-12.8(m)-11.1(i)-14.8(t a)-22.9(s)-.1( b)-16.2(e)-14.8(n)-11.7(e)-17.2(“)-19.9(t)-10.9(s c)-19.6(o)-15.8(s)-16.2(t)-11(s c)-23.3(a)-15.7(n ”)-15.9(u)-12.8(c)-17.2(t)-5.4(u)-14.6(a)-5.3(te)-20.1( )]TJ 1 i q 1 0 0 1 56.669 820.333 cm 0 0 m -.0006 Tw A typica… [(t)-8.2(h)-12.7(e d)-15(a)-4.8(te o)-9.6(f).4( ve)-19.5(s)-15.7(t)-8.1(i)-12.3(n)-10.3(g)-16.6(. 0 -1.176 TD 10.9953 0 0 10.9953 45.3349 698.873 Tm [(r)-18.6(e)-20.4(e)-18.9(m)-17.9(e)-18.9(n)-12.6(t)-23.5(. -.4199 -1.6772 TD .0001 Tw f BT -.0154 Tw << -.0188 Tc q 1 0 0 1 39.668 483.507 cm 0 0 m .75 w -.0007 Tw s BT 0 Tc 0 -1.677 TD [(en)14.8(vironmen)5.8(ts)14( encoun)5.8(t)15.2(e)-.1(red)14( b)11(y)14( t)5.4(h).9(e)14( ind)4.2(i)-2.6(viduals)-11.8(. 1 scn -.5731 0 TD /Cs6 cs .95294 .43529 .12941 scn /GS1 gs [(Opp)-21(ortunity)]TJ -.0011 Tw 0 -17.001 l 2 0 obj 0 Tc 0 -1.677 TD 0 -1.176 TD /Cs6 cs .95294 .43529 .12941 scn -.0052 Tc S 0 Tw /GS2 gs -.0062 Tc [(Other Executive Directors)-19988(5)-21(0)0(0)]TJ ).4( I)-21.7(n).4( l)-8.5(i)-12.3(n)-11.3(e).4( w)-15.8(i)-14.4(t)-8.2(h).4( t)-8.2(h)-12.7(e p)-14.8(o)-12.7(l)-8.5(i)-14.5(c)-10.1(y).4( f)-5.8(o)-12.8(r o)-7.2(t)-8.2(h)-12.7(e)-13.7(r e)-14.2(m)-12.5(p)-13.1(l)-12.7(oye)-15.7(e)-19.5(s)-23.8(,)-19.6( )]TJ )]TJ Q 74 0 R] -33.5018 -1.2 TD 0 Tc >> [(T)103(o)0( compens)-21(ate Non-Executive Directors)-20( )]TJ endobj /Cs8 cs 1 scn endobj q 1 0 0 1 56.669 713.33 cm 0 0 m /Cs8 cs 1 scn -.0203 Tc [(t)-8.7(h)-13.2(e b)-16.2(e)-20(s)-16.2(t)-.1( i)-12.8(n)-8.3(te)-14.2(r)-14.4(e)-20(s)-16.2(t)-11(s o)-10(f)-.1( t)-8.7(h)-13.2(e c)-19.7(o)-13.6(m)-13(p)-15(a)-15.6(n).7(y a)-15.8(n)-11.7(d i)-14.8(t)-11(s s)-15.1(h)-13.3(a)-15.3(r)-14.4(e)-13.7(h)-12.7(o)-13.2(l)-13.6(d)-13.7(e)-14.2(r)-23.3(s)-25.9(. /Rotate 0 -.0197 Tc -.58 0 TD [(y)12.4(e)-5(ar)44.9(,)14.5( are)14.4( pro)12.9(v)-.4(ided)14.5( in)14.4( t)5.8(h)1.3(e)14.4( A)-7.8(n)3.2(n)5.9(u).4(al)14.4( repor)-26.7(t)14.4( on)14.4( remunera)9.2(t)5.9(ion. 1 0 TD 18.1421 4.7999 TD 0 Tc [(F)-16.7(o)-13.3(r b)-15.8(o)-13.7(n)-8.6(u)-13.6(s p)-14.9(a)2.1(y)-16.7(m)-13.6(e)-14.7(n)-8.3(t)-11(s)-.1( u)-11.2(p)-.1( to a)-15.7(n)-11.8(d i)-12.8(n)-11.8(c)-15(l)-10.6(u)-14.1(d)-9.9(i)-12.8(n)-10.8(g t)-8.6(h)-13.3(e b)-15.8(o)-13.7(n)-8.5(u)-13.6(s i)-12.8(n)-.1( r)-14.4(e)-20(s)-15.5(p)-15.8(e)-16.2(c)-17.2(t)-20.1( )20.1( )]TJ [(D)-20(i)-12.4(r)-14.5(e)-16.3(c)-17.3(t)1.6(o)-13.4(r)-.2( w)-16.4(i)-11.5(l)-10.1(l)-.2( b)-16.2(e)-.2( d)-10.1(i)-14.5(s)-16.4(c)-15.1(l)-13.3(o)-15.9(s)-16.4(e)-16.3(d a)-22.9(s)-.2( s)-15.9(o)-14.9(o)-13.8(n)-.2( a)-22.9(s)-.2( p)-13.8(r)-18.7(a)-11.1(c)-17.3(t)-8.7(i)-15.1(c)-23.4(a)-15.4(b)-14.2(l)-13.7(e a)-7.8(f)-37(te)-14.3(r t)-8.8(h)-13.3(e)-20.2( )]TJ Q Our rewards package includes: A competitive base salary; An annual bonus based on company performance; Access to healthcare and wellbeing programmes, pension plan membership, savings programmes, time off and childcare support; Employee recognition programmes which reward exceptional achievements .0019 Tc [(s)-16.4(t)-9.4(r)-18.7(a)-5.5(te)-15.5(g)-10.1(i)-15.2(c p)-16(e)-14.4(r)-43.7(f)-6.5(o)-13.5(r)-18.8(m)-13.9(a)-15.9(n)-12(c)-20.2(e c)-19.7(o)-13.9(n)-12(d)-10.1(i)-15.1(t)-8.8(i)-14.8(o)-13.9(n)-10.8(s)-.3( w)-17.9(h)-10.7(i)-15.2(c)-14.4(h a)-15.5(r)-14.6(e a)-15.9(l)-9.2(i)-14.3(g)-12.8(n)-12(e)-16.3(d to t)-8.9(h)-13.4(e)-10.3( )]TJ [(Simpli“c)-21(ation of the Annual b)-20.9(onus)]TJ /Contents 25 0 R /F3 1 Tf -.0056 Tc << -.0002 Tw )Tj -.0007 Tw BT 0 .71373 .78824 scn 0 -1.176 TD [(F)-16.2(o)-12.8(r t)-8.2(h)-12.7(e P)-24(S)-22.9(P aw)-5(a)-14.8(r)-14.8(d)-14(s)-23.9(,).4( t)-8.2(h)-11.7(r)-13.9(e)-19.4(s)-14.7(h)-12.1(o)-12.7(l)-13.1(d l)-13.1(e)-2.1(ve)-13.6(l)-12.6(s).4( o)-9.6(f).4( ve)-19.5(s)-15.7(t)-8.1(i)-12.3(n)-10.3(g a)-14.8(r)-13.9(e a)-22.3(s)-22.3(s)-13.5(u)-11.1(m)-13.1(e)-15.7(d)-16.6(. [(c)-14.9(l)-14(aw)-18(b)-15.2(a)-10.9(c)-14.6(k)0( o)-13.2(r)0( m)-13.6(a)-15.6(l)-10.5(u)-13.5(s)-25.8(. [(s)-15.6(e)-9(t by r)-13.7(e)-11.3(f)-6.6(e)-13.5(r)-13.7(e)-14(n)-11.1(c)-19.3(e to c)-18.9(o)-13(m)-12.3(p)-14.2(a)-14.6(r)-17.9(a)-14.6(b)-13.4(l)-12.9(e).6( r)-12.3(o)-12.4(l)-13(e)-19.3(s i)-12.1(n).6( c)-18.9(o)-13(m)-12.3(p)-14.2(a)-15(n)-8.4(i)-14.3(e)-19.3(s o)-9.4(f).6( e)-15.1(q)-10.9(u)-8.3(i)-16(va)-15(l)-12.9(e)-14(n)-7.6(t).6( s)-14(i)-15.6(ze)-19.4( )]TJ 239.677 -441.701 239.677 -433.201 v /F3 1 Tf -.0155 Tw /Type /Page -.0199 Tc 0 -1.677 TD )]TJ (All scenarios:)Tj 0 -1.154 TD .0001 Tw -.014 Tw /F3 1 Tf .01 Tc /ExtGState 55 0 R 0 -17 l [(A)-22.2(n).8(y m)-14(a)-15.2(j)-12.1(o)-13.2(r a)-11.4(d)-14(j)-10.6(u)-13.5(s)-16.1(t)-9.6(m)-13.5(e)-14.6(n)-8.2(t).1( i)-12.7(n)0( t)-8.6(h)-13.1(e c)-23.2(a)-15.6(l)-13.5(c)-12.9(u)-9.8(l)-14(a)-5.1(t)-8.5(i)-14(o)-14(n)0( o)-10(f)0( p)-15.7(e)-14(r)-43.5(f)-6.2(o)-13.1(r)-18.5(m)-14(a)-15.6(n)-11.7(c)-19.9(e m)-13.5(e)-19.4(a)-22.7(s)-14(u)-11(r)-14(e)-19.9(s)0( w)-16.2(i)-11.3(l)-9.9(l)-20( )]TJ (legal and/or professional advice. 0 -1.677 TD I have a question that is not covered in the above –what do I do? 0 Tw -.0011 Tw /F3 1 Tf 498.684 0 l 0 -1.176 TD -.0003 Tw /F1 1 Tf 0 -1.176 TD [(t)5.4(h).9(e)14( problem)14( is)14( iden)5.7(t)5.6(i)-8.2(“)-5.2(e)-2.1(d)14( and)14( f)7.8(o).8(r)14.1( fut)8.7(u)2.9(re)14( periods)-11.8(. 0 Tw /MediaBox [0 0 595.2199707031 842] q 1 0 0 1 311.124 268.732 cm 0 0 m )]TJ )-.6( F)-17.2(o)-13.8(r t)-9.2(h)-13.7(e)-20.5(s)-16.8(e p)-12.7(u)-11.7(r)-18.6(p)-15.8(o)-16.3(s)-16.7(e)-20.6(s)-.6( �)-7(p)-15.4(ay)-17.3(m)-14.1(e)-15.2(n)-8.8(t)-11.5(s� i)-13.2(n)-12.3(c)-15.5(l)-11.1(u)-14.6(d)-14.2(e)-20.5(s)-.6( t)-9.2(h)-13.7(e C)-29.9(o)-14.2(m)-13.7(m)-11.6(i)-15.4(t)-29(te)-16.7(e)-20.6( )]TJ A)-17.6(s).3( t)-8.3(h)-12.8(e n)-11.4(e)-3.6(w C)-22.8(E)4.2(O a)-15.4(n)-11.3(d P)-21.4(r)-14(e)-19.5(s)-14.3(i)-14.6(d)-13.3(e)-14.3(n)-7.9(t)-18.3(,).3( R)-8.7(&)-20.9(D we)-13.8(r)-14(e).3( n)-10.9(o)-7.3(t i)-12.4(n)-19.7( )]TJ )]TJ [(i)-16.8(.)-8.3(e)-14.2(. /F3 1 Tf T)-19.1(h)-12.4(e)-19.2(s)-15.5(e i)-12(n)-11(c)-14.2(l)-9.8(u)-13.3(d)-12.9(e)-14.7(,)-19.3( )]TJ -.001 Tw -.0002 Tw /Cs8 cs 1 scn ET stream 0 Tw 0 Tw -.0135 Tw f >> -.007 Tc 243.676 -22.668 243.676 -17.001 v -.02 Tc BT q 1 0 0 1 56.669 137.789 cm 0 0 m [(H)-5.2(o)11.1(w)10.6(e)11.7(v)12(e).1(r)44.6(,)14.1( t)5.5(h)1(ere)14.1( ma)16.3(y)14.2( be)14.1( unf)7.9(o).9(re)-5.8(seen)14.1( circumstanc)-5.8(e)-5.8(s)14.1( where)14.2( t)5.6(h)3.7(is)14.1( is)14.1( in)-5.9( )16.8( )]TJ 0 -16.36 l -.0018 Tc 0 -1.176 TD /Cs8 CS .65 SCN 41 0 obj 245.092 -22.668 245.092 -17.001 v [(T)20(he Chairman and C)-21(E)-21(O)0( are responsible for evaluating and making recommendations to the)-20( )]TJ [(N)-5(o)7.8( ma)9.1(t)15.8(e).1(rial)7.8( change)]TJ ET << Q /F1 77 0 R -.0049 Tc /F3 1 Tf /F1 1 Tf 239.426 -22.668 l 0 -1.578 TD -.0198 Tc -.0196 Tc 0 Tw -.0003 Tw -.0202 Tc 0 -1.176 TD -8.7869 1.093 TD [(O)-18.4(u)-13.5(t)-11.1(s)-16.3(t)-18.3(a)-15.8(n)-11.9(d)-10(i)-12.9(n)-10.9(g m)-13.8(a)-5.4(tc)-14.3(h)-10.6(i)-12.9(n)-10.9(g)-.2( aw)-5.6(a)-15.4(r)-15.4(d)-14.6(s a)-15.4(r)-14.5(e s)-14.1(u)-11.3(b)-12.3(j)-12.9(e)-16.3(c)-17.2(t to t)-8.8(h)-13.3(e s)-22.5(a)-15.8(m)-13.7(e)-.2( m)-13.7(e)-19.6(a)-22.9(s)-14.1(u)-11.3(r)-14.5(e)-20.1(s)-.2( a)-22.9(s)-20.2( )]TJ T* >> 0 Tw [(F)-17.5(e)-15.6(e)-19.4(s).5( w)-15.7(i)-10.8(l)-9.4(l).5( b)-15.6(e).5( s)-15.7(e)-9.1(t a)-4.7(t).5( a l)-13(e)-2(ve)-13.5(l t)-8.1(h)-12.7(a)-4.7(t).5( i)-13.9(s).5( c)-19(o)-13.1(m)-12.4(p)-15.2(e)-9.2(t)-7.9(i)-14.3(t)-8(i)-16.1(v)-1.6(e w)-15.7(i)-14.3(t)-8.1(h).5( t)-8.1(h)-12.1(o)-15.2(s)-15.7(e p)-14.3(a)-14.2(i)-14.4(d).5( by)-19.5( )19.7( )]TJ /Cs6 cs 0 .71373 .78824 scn T* 0 -1.1759 TD q /GS2 gs Q -.0003 Tw [(o)-10.3(f)-.3( t)-8.9(h)-13.4(e D)-20.1(i)-12.5(r)-14.6(e)-16.4(c)-17.4(t)1.5(o)-13.5(r)-23.5(s� R)-11.4(e)-14.8(m)-11.5(u)-11.7(n)-12(e)-14.5(r)-18.7(a)-5.5(t)-8.9(i)-14.7(o)-13.9(n)-.3( R)-11.4(e)-14.4(p)-15.5(o)-13.5(r)-41.4(t)-.3( a)-15.5(r)-14.6(e n)-11.5(o)-7.9(t s)-14.2(u)-11.4(b)-12.4(j)-13(e)-16.4(c)-17.4(t to a)-11.7(u)-14.3(d)-10.1(i)-15.1(t n)-11.5(o)-13.5(r)-20.3( )20.3( )]TJ [(D)-30(r).3( P)-22.9(a)-20(t)-27.5(r)-15(i)-23.3(c)-19.4(k Va)-17.8(l)-16.5(l)-23.7(a)-17.8(n)-23.6(c)-21.3(e)-38.3(, P)-21.1(r)-18.1(e)-22.7(s)-17.2(i)-19.2(d)-19.6(e)-21.8(n)-19.5(t)-56.4(,).3( R)-7.7(&)-28.9(D \()6.8(£)-36.6(0)-44(0)-43.9(0\))]TJ /Resources 16 0 R 0 -1.2 TD 0 -1.1759 TD /CropBox [0 0 595.2199707031 842] [(cial)-20( )]TJ 11.8681 0 TD /F1 1 Tf 0 Tw 76.503 0 l /Cs6 cs .38431 .73333 .27451 scn -.02 Tc -.0006 Tw ET -.0003 Tw -.006 Tc -.0058 Tc -8.716 -21.488 TD /Cs6 [/ICCBased 73 0 R] f /ExtGState 35 0 R /F3 1 Tf (Operation)Tj -.0007 Tw 0 Tw 8.4964 0 0 8.4964 55.9603 676.79 Tm 8.4964 0 0 8.4964 40.8014 676.79 Tm Q 353.613 275.875 19.833 11.173 re << T* /Cs8 CS 1 SCN 478.709 441.439 19.833 33.75 re -.0001 Tw [(to t)-8.2(h)-11.7(r)-13.9(e)-15.7(e ye)-19(a)-14.8(r)-22.8(s� a)-15.2(n)-10.8(n)-8.1(u)-14.1(a)-15.2(l).4( a)-15.2(n)-11.3(d d)-13.2(e)-11.5(f)-6.8(e)-13.7(r)-17.6(r)-13.9(e)-15.7(d).4( b)-15.3(o)-13.2(n)-8.1(u)-13.1(s)-15.8(e)-19.5(s a)-22.3(s).4( we)-13.6(l)-9.5(l).4( a)-22.3(s).4( ve)-19.5(s)-15.7(t)1.6(e)-15.7(d).4( a)-15.2(n)-11.3(d)-19.6( )]TJ 0 -1.677 TD [(£2)-4.2(. S 1 0 0 1 -212.507 -93.503 cm 0 0 m /F1 1 Tf q 1 0 0 1 39.668 713.33 cm 0 0 m [(st)-21(ance,)-20( )]TJ -.0062 Tc 3.998 w -.02 Tc >> [(R)-11.5(e)-15(m)-11.5(u)-11.9(n)-12.1(e)-14.4(r)-18.9(a)-5.6(t)-8.9(i)-14.4(o)-14.4(n)-.4( a)-15.6(r)-14.4(e s)-14.4(u)-11.4(b)-12.5(j)-13.1(e)-16.5(c)-17.5(t to a)-11.8(u)-14.4(d)-10.2(i)-15.1(t)8.5(:)-.4( to)-8(t)-18.5(a)-16(l r)-14.4(e)-15(m)-11.4(u)-12(n)-12(e)-14.4(r)-18.9(a)-5.6(t)-8.9(i)-14.4(o)-14.4(n)-.4( “)-18.7(g)-11.8(u)-11.5(r)-14.4(e)-20.3(s)-.4( f)-6.6(o)-13.6(r)-20.4( )]TJ The homepage of the GSK USA website. [(24)-13.4(%)]TJ 0 -1.677 TD -.0006 Tw 0 -1.176 TD 18 0 obj BT -.42 -1.6767 TD [(CF)21(O)-28306.9(4)0(0)21(0)]TJ -.0003 Tw 243.758 0 l ©2020 GSK or licensor. >> endobj -.02 Tc /Pages 2 0 R BT T* /Contents 15 0 R >> 7.9966 0 0 7.9966 38.5347 677.1639 Tm -.02 Tc )]TJ [(companies of equivalent size and)-20( )]TJ [(g)-13.6(e)-15.7(o)-14.3(g)-12(r)-18.5(a)-15.2(p)-13.2(h)-.6(y i)-12.7(n)0( w)-17.6(h)-10.4(i)-14.9(c)-14.1(h t)-8.6(h)-13.1(e E)-41(x)-4.8(e)-16.1(c)-12.9(u)-13.3(t)-8.5(i)-16.6(v)-2.1(e D)-19.8(i)-12.2(r)-14.3(e)-16(c)-17.1(t)1.7(o)-13.1(r)0( i)-14.4(s)0( b)-15.2(a)-22.7(s)-16.2(e)-16.1(d a)-15.6(n)-11.7(d d)-9.8(i)-17.1(f)-39.2(f)-7.2(e)-14.1(r)-14.3(e)-14.6(n)-8.2(t)-20( )]TJ [(No)5.7(n)7.3(e)4.8(. 30.053 9.912 TD .0003 Tw >> )-6( )]TJ 8 0 obj -.0202 Tc 52 0 obj [(A)-6(ppro)-4.1(a)-3.6(ch to re)-8.9(cruit)-10.2(m)-3.1(e)-3.6(n)-1(t re)-3.6(munerat)-10.4(i)1.7(on)]TJ -.0001 Tw 6.7471 0 0 7.4968 399.5138 751.8947 Tm S -.0001 Tw /GS2 gs 0 -1.176 TD 0 -1.2 TD >> T* /GS2 gs 30.004 16.971 TD -.0093 Tc [(of the Remuneration policy)41(. .0034 Tc [(T)58.3(o).2( p)-13.4(r)-12.7(ov)-14.6(i)-14.7(d)-13.4(e a c)-19.3(o)-13(r)-14.1(e).2( r)-14.1(e)-3.7(w)-5.2(a)-15(r)-15(d).2( f)-6(o)-13(r t)-8.4(h)-12.9(e r)-12.7(o)-12.9(l)-13.3(e)-14.3(. .0002 Tw T* BT -.001 -2.643 TD -.5799 0 TD -.0022 Tc 0 -1.2001 TD .0003 Tw -.015 Tc /Cs8 cs 1 scn /ArtBox [0 0.1659999937 595.0200195312 841.6939697266] 0 Tw .0001 Tw /F1 1 Tf ).6( I)-28.1(f).6( t)-12.7(h)-17.2(e te)-18.1(r)-22.5(m)-15(i)-16.7(n)-15.8(a)-9.4(t)-12.6(i)-18.5(o)-17.7(n d)-19.5(a)-9.4(te f)-16.4(a)-19.7(l)-14(l)]TJ f 53 0 obj 0 Tc )]TJ /Cs6 cs 0 .71373 .78824 scn 0 -1.6769 TD 0 -1.1759 TD ( )Tj /Cs6 [/ICCBased 73 0 R] -.0196 Tc 74 0 R] .58 -1.1765 TD 0 -17.001 5.667 -17.001 v -.0002 Tw << [(A)14( c)-5.5(o)0(mbina)8.8(t)5.5(ion)14( of)14( per)-29.4(f)7.8(ormanc)-5.9(e-rela)8.8(t)15.2(e)-2.1(d)14( and)14( re)-5.9(strict)15.2(ed)14( share)14.1( plans)-6( )]TJ << q 1 0 0 1 56.669 569.825 cm 0 0 m Q /F1 1 Tf [( If an individual serves notice and the termination date falls before 31 December)41.1(, the bonus is)-20.1( )]TJ T* 0 -1.176 TD 1.999 w 4 M ET -53.6738 -1.2 TD -.025 Tc [(Remo)12.4(v)11.9(e)-2.6(d)7.2( from)7.3( 2)11.8(0)38.8(1)92.6(7)7.2( on)13.4(w)8.5(ards)]TJ 286.177 0 l -.0038 Tc )Tj -.0001 Tw -.0162 Tw [(a)-22.2(s)-22.2(s)-15.7(e)-19.4(s)-22.2(s)-14.1(i)-12.2(n)-10.2(g).5( a)-15.1(n)-10.7(n)-8(u)-14(a)-15.1(l).5( b)-15.2(o)-13.1(n)-8(u)-13(s aw)-4.9(a)-14.7(r)-14.7(d)-13.9(s a)-15.2(n)-11.2(d L)51.4(T)-24(I ve)-19.4(s)-15.6(t)-8(i)-12.2(n)-10.2(g l)-13(e)-2(ve)-13.5(l)-12.5(s).5( i)-12.2(n).5( t)-8.1(h)-12.6(e ye)-18.9(a)-14.7(r)-19.5( )20.1( )]TJ ET f 1 i -29.949 -6.231 TD 0 Tw -.014 Tw -.0142 Tc S [(o)-10(f)0( t)-8.6(h)-13.1(e G)-21.2(r)-12.8(o)-11.7(u)-11.1(p)-10.4(. 1.134 -1.2001 TD (Expected:)Tj 12.1508 0 TD .0002 Tw -.0203 Tc /Count 10 [(D)-19(u)-10.8(r)-15.9(i)-12.4(n)-10.4(g).3( 20)23.9(1)50.1(6)-17.8(, t)-8.3(h)-12.7(e C)-29(o)-13.3(m)-12.8(m)-10.7(i)-14.4(t)-28.2(te)-15.8(e r)-14(e)-2.2(v)-14.5(i)-14.6(ewe)-15.8(d).3( t)-8.3(h)-12.8(e R)-10.8(e)-14.3(m)-10.8(u)-11.2(n)-11.4(e)-13.8(r)-18.2(a)-4.9(t)-8.2(i)-14.2(o)-13.3(n).3( p)-14.9(o)-12.8(l)-8.6(i)-14.6(c)-10.2(y).3( to)-19.7( )]TJ /Cs6 cs 1 1 1 scn /F1 1 Tf .01 Tc )-19.7( )]TJ [(t)-21(aking into account the proportion of the performance period that has elapsed. T* [(r)-12.7(o)-12.9(l)-13.3(e)-15.2(, t)-8.4(h)-12.9(e m)-13.4(a)-15(r)-17.8(k).2(e)-9.4(t).2( f)-13.6(r)-12.7(o)-13.4(m).2( w)-17.3(h)-10.3(i)-14.7(c)-13.8(h t)-8.4(h)-12.9(ey w)-16(i)-11.1(l)-9.7(l).2( o)-13(p)-15.5(e)-13.9(r)-18.3(a)-5(t)1.4(e a)-15.4(n)-11.5(d t)-8.4(h)-12.9(e)-12.9(i)-12(r e)-5.6(x)-16.9(p)-15.5(e)-13.9(r)-16(i)-14.7(e)-14.4(n)-11.5(c)-19.7(e)-14.3(. (removed. T)-19(h)-12.3(ey d)-12.4(o).8( n)-10.4(o)-6.8(t i)-11.9(n)-10.9(c)-14.1(l)-9.7(u)-13.2(d)-12.8(e a)-14.8(m)-12.3(o)-10.9(u)-10.7(n)-7.4(t)-10.1(s i)-11.9(n)-19.2( )]TJ 0 -17.001 6.997 -17.001 v 6.997 0 0 6.997 419.0648 251.1992 Tm [(\(other than the Chairman\) for t)-21(aking on)-20( )]TJ S 1 0 0 1 0 -42.112 cm 0 0 m [(C)-15.1(o).2(mmit)-14.1(t)15.4(e)-1.9(e)14.2( e)8.4(x)9.4(ercise)-5.7(s)14.2( t)5.6(h)3.8(is)14.2( aut)5.6(h)1.7(orit)-15.1(y)14.2( f)8(o)1(r)14.2( t)5.6(h)1.2(e)14.2( wider)14.2( emplo)12.2(y)12.2(e)-1.9(e)14.2( ba)-8.5(se. -.02 Tc 208.981 0 l [(of)10.9( the)10.9( or)-3.3(g)-4.5(a)-4.7(ni)-3.5(s)-11.4(a)5.7(ti)-3.6(on)29.4(;)]TJ -.0135 Tw -.42 -1.6791 TD /Length 49 0 R -.0128 Tc /Cs8 cs 1 scn [(remunera)8(t)4.7(ion)13.2( elemen)5.1(ts)13.2( will)13.2( c)-6.3(o)-.8(n)5(t)4.7(in)4.7(ue,)13.2( including)13.3( pension )8.7( )]TJ 8.7869 .0409 TD /F3 1 Tf )]TJ 0 -17.001 l [(c)-5.8(o).1(mpared)13.7( t)15.5(o)13.7( o)6.2(t)5.1(her)13.7( phar)-4.7(m).1(ac)-6.2(eutic)-9.5(al)13.8( c)-5.8(o).1(mpanie)-6.2(s)-12(. -.0198 Tc 0 -1.176 TD )-20( )]TJ ET [(o)-9.7(f)-44(“)-18.9(c)-19.6(e)13.5(;).3( a)-15.3(n)-11.4(d s)-14.7(h)-12.9(a)-14.9(r)-14(e ow)-18.2(n)-11.4(e)-13.8(r)-22.9(s)-14.7(h)-10.1(i)-11.9(p r)-13.9(e)-15.4(q)-11.2(u)-8.7(i)-11.9(r)-13.9(e)-14.3(m)-13.2(e)-14.3(n)-7.9(t)-10.6(s).3( a)-15.3(n)-11.4(d h)-12.3(o)-12.8(l)-13.2(d)-9.5(i)-12.4(n)-10.4(g)-14.1(s)-24(, f)-5.9(o)-12.9(r w)-17.3(h)-10.1(i)-14.6(c)-13.8(h t)-8.3(h)-12.8(e)-19.7( )]TJ .0042 Tc 498.684 -22.667 498.684 -17.001 v -.0143 Tw S 6 0 obj endobj [(I)-8.5(n)2(cre)-6(a)-9.4(s)-2.6(e)7.2( in)7.2( requ)4.9(iremen)5.6(t)7.2( f)7.5(o).5(r)7.2( C)-9.2(E)18.6(O)]TJ 76.503 0 l [(L)103(TI awar)20(ds)-20( )]TJ )14( Such)14( arrangemen)5.8(ts)14( will,)14( where)14( pos)-8.7(s)-.6(ible,)-5.9( )20( )]TJ Registered in England and Wales No. f /F1 1 Tf /Cs8 cs 1 scn -.0065 Tc -.0202 Tc [(s)-14.9(h)-13.1(a)-15.1(r)-14.2(e)-13.5(h)-12.5(o)-13(l)-13.4(d)-13.5(e)-14(r)-23.1(s).1( a)-15.1(r)-14.2(e b)-16(e)-13(i)-12.6(n)-10.6(g a)-22.6(s)-15.3(ke)-16.1(d to a)-15.1(p)-13.6(p)-13.5(r)-12.7(ove a n)-11.5(e)-3.8(w R)-11(e)-14.5(m)-11(u)-11.4(n)-11.6(e)-14(r)-18.4(a)-5.1(t)-8.4(i)-14.4(o)-13.5(n).1( p)-15.1(o)-13(l)-8.8(i)-14.8(c)-10.4(y)-19.9( )]TJ 0 -1.1759 TD BT 0 -1.677 TD >> /F3 1 Tf /Cs8 [/Separation /PANTONE#20Warm#20Gray#209#20C [/ICCBased 73 0 R] Glassdoor is your resource for information about GlaxoSmithKline benefits and perks. Q [(a)-15.6(n)-11.7(d i)-14.4(s)0( b)-15.2(a)-22.7(s)-16.2(e)-16.1(d o)-13.6(n)0( b)-12.6(u)-13.5(s)-14.6(i)-12.7(n)-11.7(e)-19.9(s)-22.7(s)0( a)-15.6(n)-11.7(d i)-12.7(n)-11.7(d)-9.8(i)-16.6(v)-14.8(i)-14.9(d)-11.1(u)-14.6(a)-15.6(l)0( p)-15.7(e)-14.1(r)-43.4(f)-6.3(o)-13.1(r)-18.5(m)-13.6(a)-15.6(n)-11.7(c)-19.9(e)-14.5(. [(p)-15(e)-13.4(r)-42.8(f)-5.5(o)-12.5(r)-17.8(m)-12.8(a)-14.9(n)-11.1(c)-19.1(e s)-7.4(y)-8.4(s)-15.4(t)1.9(e)-13.9(m).7( f)-5.5(o)-12.5(r)-17.8(m)-12.9(a)-14.9(l)-9.2(l)-13.5(y).7( eva)-14.9(l)-9.8(u)-13.8(a)-4.5(te)-19.2(s e)-13.9(m)-12.2(p)-12.8(l)-12.4(oye)-15.3(e)-19.3(s).7( o)-12.9(n).7( b)-15(o)-6.9(t)-7.9(h).7( �)-19.1(w)-16.9(h)-12.5(a)-4.5(t)-23.4(�).7( )]TJ /Cs8 cs 1 scn 11.8681 0 TD q 1 0 0 1 39.668 342.583 cm 0 0 m endobj 498.684 0 l W n BT /BleedBox [0 0.2860000134 595.0200195312 841.8140258789] -.056 Tc << -.0203 Tc [(in)14.2( t)5.6(h)1.1(e)14.2( A)-8(n)3(n)5.7(u).2(al)14.2( repor)-26.9(t)14.2( on)14.3( remunera)9(t)5.7(ion. [(U)-3.8(S)1.8(/)-7.9(U)-15.6(K)12.8( ar)-5.2(r)-5.7(a)-2.8(ngements)-13(. /Cs8 cs 1 scn 74 0 R] /ExtGState 43 0 R 13.8514 0 TD /Cs6 cs .95294 .43529 .12941 scn /Filter /FlateDecode T* QfÊ ÃMlˆ¨@DE� €£¡H¬ˆb!(¨`HPb0Š¨¨dFÖJ|yyïåå÷ǽßÚgïs÷Ù{Ÿµ. /GS2 76 0 R 9.9299 0 TD 10.2051 0 TD 1 1 1 scn /Cs8 cs .65 scn S .0001 Tw /Cs6 cs 1 1 1 scn 3888792. /F3 1 Tf [(Bene“t)-13.7(s)8.3( )]TJ -.01 Tc /F3 78 0 R q 1 0 0 1 39.668 300.593 cm 0 0 m ET .01 Tc 396.68 763.915 158.672 15.584 re [(B)-18.6(o)-13.3(a)-14.7(r)-14.7(d).5( o)-9.5(f).5( D)-19.3(i)-11.7(r)-13.8(e)-15.6(c)-16.6(t)2.3(o)-12.7(r)-22.6(s a)-15.2(n)-11.1(d s)-14.1(i)-13.5(g)-12(n)-11.2(e)-15.6(d).5( o)-13.1(n).5( i)-14.3(t)-10.4(s b)-15.6(e)-13.1(h)-12.7(a)-15.1(l)-15.2(f).5( by)-19.5( )]TJ /GS1 75 0 R /F3 1 Tf [(E)-26.8(x)9.4(ecut)5.7(iv)12.1(e)14.2( D)-5.6(i)2(rect)16.1(or)-9(s)17.6(�)14.2( long-)17(t)15.4(erm)14.2( remunera)9(t)5.7(ion)14.2( on)14.2( t)5.6(h)1.1(e)14.3( del)5.3(i)-2.4(v)12.1(e).2(r)-27.8(y)14.2( of)14.2( GS)-13.4(K)-13(�)31.3(s)-5.8( )]TJ GSK is proud to be recognized for the 5th year in a row as a Glassdoor UK Best Places to Work! -.02 Tc /CropBox [0 0 595.2199707031 842] -.0289 Tc -.0067 Tc The Twin Cities is an appropriate venue to address trends in international relocation, as the metro area has long been a vanguard of international business. f -.4201 -1.5114 TD 0 Tw [(Non-Executive Director)41(. [(adjustmen)5.9(t)3.2(s)14.1( ma)16.3(y)14.1( also)14.1( re”ect)14.1( wider)14.1( mark)14(et)14.1( c)-5.4(o).6(ndit)5.6(ions)14.1( in)14.2( t)5.5(h)1(e)-5.9( )]TJ ET T* -.0006 Tw -.0202 Tc )-9.2(8)-8.1(5m)]TJ -.0005 Tw 498.684 0 l /Cs8 cs 1 scn endobj -.0055 Tc -.0005 Tw 0 -1.176 TD /GS2 76 0 R endobj 73 0 obj [(le)10.9(v)11.3(e)-.6(ls)13.4( of)13.4( v)9(a)-1.8(riable)13.4( pa)15.6(y)13.4( in)13.4( GS)-14.2(K)-13.9(�)30.5(s)13.5( global)13.4( phar)-5.1(m)-.2(ac)-6.5(eutic)-9.8(al)13.4( c)-6.1(o)-.2(mpetit)15.2(or)-9.8(s)-12.4(. 0 -1.767 TD ET -.0185 Tc /F1 1 Tf S 1 0 0 1 212.507 0 cm 0 0 m 0 J 0 j 1.999 w 4 M [] 0 d 4 0 obj /GS1 75 0 R /Cs6 cs .95294 .43529 .12941 scn /ColorSpace 42 0 R 0 Tw 25 0 obj 0 -1.1759 TD -.0197 Tc f )Tj 0 Tw f -.02 Tc )Tj << [(the 20)47(1)41(7)0( D)20(A)0(B)-42(P)0( rules, the following provisions will normally apply:)]TJ /Cs8 cs 1 scn -.0067 Tc 0 -17.001 5.667 -17.001 v /Cs6 cs 1 1 1 scn 0 -1.677 TD >> S (continued)Tj [(B)-21(oard on the fees payable to the company�)62(s Non-Executive Directors. BT [(35)11(%)]TJ T*

Don't You Need Somebody To Love Tiktok Remix, Neo Geo Games List, Lost Knife Hideout Sabercat, Kashi Cinnamon French Toast Nutrition, Kevin Plank Height,


Recommended Posts

Leave a Reply

Your email address will not be published. Required fields are marked *